Recent Finacing
Recent Raise
Skyline Vet Pharma reformulates in-licensed human drugs into palatable, easier-to-administer, less‑frequently dosed combination products for companion animals across pain/inflammation, cardiovascular, and antimicrobial therapeutic franchises.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor